These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21685237)

  • 1. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
    Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
    Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
    de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
    Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
    Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
    Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration.
    Leite EA; Giuberti Cdos S; Wainstein AJ; Wainstein AP; Coelho LG; Lana AM; Savassi-Rocha PR; De Oliveira MC
    Life Sci; 2009 May; 84(19-20):641-9. PubMed ID: 19302806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
    Leite EA; Souza CM; Carvalho-Júnior AD; Coelho LG; Lana AM; Cassali GD; Oliveira MC
    Int J Nanomedicine; 2012; 7():5259-69. PubMed ID: 23091378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal toxicity evaluation of long-circulating and pH-sensitive liposomes loaded with cisplatin.
    Araújo RS; Silveira ALM; de Sales E Souza ÉL; Freire RH; de Souza CM; Reis DC; Costa BRC; Sugimoto MA; Silveira JN; Dos Santos Martins F; Cassali GD; Leite JIA; Sousa LP; Ferreira AVM; Oliveira MC; Cardoso VN
    Eur J Pharm Sci; 2017 Aug; 106():142-151. PubMed ID: 28546107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin.
    dos Santos Giuberti C; de Oliveira Reis EC; Ribeiro Rocha TG; Leite EA; Lacerda RG; Ramaldes GA; de Oliveira MC
    J Liposome Res; 2011 Mar; 21(1):60-9. PubMed ID: 20429813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice.
    Leite EA; Lana AM; Junior AD; Coelho LG; De Oliveira MC
    J Biomed Nanotechnol; 2012 Apr; 8(2):229-39. PubMed ID: 22515074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
    Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
    Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
    Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary data of the antipancreatic tumor efficacy and toxicity of long-circulating and pH-sensitive liposomes containing cisplatin.
    Carlesso FN; Araújo RS; Fuscaldi LL; Mendes Miranda SE; Rubello D; Teixeira CS; Dos Reis DC; Leite EA; Silveira JN; Fernandes SO; Cassali GD; de Oliveira MC; Colletti PM; de Barros AL; Cardoso VN
    Nucl Med Commun; 2016 Jul; 37(7):727-34. PubMed ID: 27007915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
    Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
    Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
    Los G; Mutsaers PH; Ruevekamp M; McVie JG
    Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
    Kondo A; Maeta M; Oka A; Tsujitani S; Ikeguchi M; Kaibara N
    Br J Cancer; 1996 May; 73(10):1166-70. PubMed ID: 8630273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
    Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
    Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
    Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
    Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
    Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
    Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.